Old Web
English
Sign In
Acemap
>
Paper
>
LTBK-12. EORTC 26951, RANDOMIZED STUDY OF ADJUVANT PCV AFTER 59.4 GY RADIOTHERAPY: VERY LONG TERM FOLLOW-UP
LTBK-12. EORTC 26951, RANDOMIZED STUDY OF ADJUVANT PCV AFTER 59.4 GY RADIOTHERAPY: VERY LONG TERM FOLLOW-UP
2019
Martin J. van den Bent
Khê Hoang-Xuan
Alba A. Brandes
Johan M. Kros
M C M Kouwenhoven
Martin J.B. Taphoorn
Jean-Yves Delattre
Hans J.J.A. Bernsen
Marc Frenay
Nathalie E. Synhaeve
Michael Weller
Roelien H. Enting
Pim J. French
Winand N. M. Dinjens
Vassilis Golfinopoulos
Thierry Gorlia
Keywords:
Internal medicine
Adjuvant
Oncology
Pathology
Radiation therapy
Randomized controlled trial
Medicine
Surrogate endpoint
Vincristine
Procarbazine
Chemotherapy regimen
Progression-free survival
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]